Category Archives: Europe

England's Cancer Drug Fund: An Acid Test for Value Based Pricing

By Leela Barham. England’s Cancer Drugs Fund (CDF) could be in its final financial year, after running in full since April 2011.  The fund covers the cost of cancer treatments either when NICE has said ‘no’, or hasn’t yet come to a view.  Companies can’t circumvent NICE though; if a company was invited to submit to [...]
Also posted in Global, Guest Blog, Op-Ed, pricing | Tagged , , , , , | Leave a comment

Marketing: Harnessing the Power of 'Pull'

Pull marketing – rethinking channel building A big problem Since the early days of the internet, we’ve been busy creating websites and other digital channels. It’s not an exaggeration to say that most pharmaceutical companies already have hundreds of websites and still more are coming. And now everybody is building apps. There’s a lot of activity here and in many ways [...]
Also posted in Global, Guest Blog, Marketing, Strategy | Tagged , , , | Leave a comment

Healthcare Systems in Europe "Failing Patients"

By Reflector, Brussels correspondent. Any complacency that the world of healthcare might be feeling about advances in the ability to treat patients suffered a head-on assault in Dublin, Ireland, last week, at a conference organized under the auspices of the Irish Presidency of the European Union and featuring a galaxy of Irish and European stars from [...]
Also posted in Guest Blog, Op-Ed, healthcare | Tagged , , , , , , | 1 Comment

AstraZeneca's R&D Trimdown, Points to Shift in The Way Big Pharma Invents

AstraZeneca’s decision to cut 5,050 jobs by 2016 and cease R&D operations at its Alderley Park, UK facility has many wondering where CEO Pascal Soriot plans to take the company. The opening of a new $500 million facility in Cambridge is at once a consolation prize for the UK government’s efforts to placate a skittish [...]
Also posted in Biotech, R&D, Strategy | Tagged , , | Leave a comment

Global Patent Management Made Easy

Patent Management Made Easy Even with a successfully launched start-up or spin-out to your name, you may still be tempted to close your eyes to the complexities of IP. But it’s actually very simple, writes Jason Rutt. So, you have done it. You have left big business or forsaken the dusty halls of academia to launch that [...]
Also posted in Global, Guest Blog, IP, Legal | Tagged , , , | Leave a comment